Personalizing Your Semaglutide Schedule with Genetic Insights Your individual response to semaglutide depends partly on genetic variants in GLP-1 receptor signaling and appetite-regulating pathways
We offer mobile IV therapy across London, with treatments available at your home, hotel, or office
Our body composition scanner measures fat mass, muscle, and visceral fat, so your provider can track what is actually changing rather than relying on the scale alone
Aliment Pharmacol Ther 2006;25:19-37
When medically appropriate, we prescribe GLP-1s for conditions like cardiac and vascular disease, sleep apnea, kidney disease, type 2 diabetes and stroke risk